8 Coupons
-
Special Offer
-
30% off
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death. .
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian. . .
services
-
.
- .